Nxera Pharma Co Ltd - Nxera To Receive Us$4.8 Mn In Milestone Payments Following Centessa's Initiation Of Clinical Development Of Orx142, A Novel Ox2r Agonist
July 4 (Reuters) - Centessa Pharmaceuticals PLC 260y.F:
NXERA PHARMA CO LTD: NXERA TO RECEIVE US$4.8 MN IN MILESTONE PAYMENTS FOLLOWING CENTESSA'S INITIATION OF CLINICAL DEVELOPMENT OF ORX142, A NOVEL OX2R AGONIST
Further company coverage: [260y.F]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.